Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies

Background: Since the efficacy of ranibizumab (RBZ), bevacizumab (BVZ) and aflibercept (AFB) is comparable in neovascular age-related macular degeneration (AMD), we conducted a systematic review and meta-analysis to evaluate the long-term safety profiles of these agents, including ocular safety. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Plyukhova, Anna A., Budzinskaya, Maria V., Starostin, Kirill M., Rejdak, Robert, Bucolo, Claudio, Reibaldi, Michele, Toro, Mario D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291235/
https://www.ncbi.nlm.nih.gov/pubmed/32443612
http://dx.doi.org/10.3390/jcm9051522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291235/
https://www.ncbi.nlm.nih.gov/pubmed/32443612
http://dx.doi.org/10.3390/jcm9051522

Ejemplares similares